Profile of:

Shue-Fen Luo

Full name: Shue-Fen Luo

Current country: Taiwan

Membership level: Associate

Type of membership: Member

Number of publications: 7

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)

Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan. (2021)

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial (2021)

Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis. (2019)

Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the World (2019)

Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. (2016)